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Abstract
Aim Randomized trials comparing surgical techniques
for rectal prolapse are not always feasible. We assessed
whether non-randomized comparisons of those who
have had surgery with those still waiting would be con-
founding baseline health status.
Method This was a prospective cohort study in seven
UK hospitals. Participants were ≥ 18 years and listed
for surgical interventions of equivalent intensity for rec-
tal prolapse. They were defined as short or long waiters
(≤ 18 or > 18 weeks, respectively). Time on the waiting
list was compared with baseline comorbidity (Charlson
comorbidity index) and change from baseline in health
status (EQ-5D-5L) at the time of surgery.
Results In all, 203 patients were analysed. Median (in-
terquartile range) waiting time was 13.7 weeks (8.1,
20.4) varying across sites. Baseline comorbidity was not
an important predictor of waiting time. Median Charl-
son comorbidity index was 2 (0, 3) for short and 1 (0,
3) for long waiters. A change in waiting time by a week
was associated with negligible improvement in the EQ-
5D-5L index of 0.001 (95% CI −0.000 to 0.003,
P = 0.106).
Conclusion Negligible change in patient reported
health status while on the waiting list and lack of effect
of comorbidities in influencing waiting time support the
use of non-randomized pre-/post-studies to compare
the effects of surgical interventions for rectal prolapse.
Keywords waiting list, comorbidity, health status, rec-
tal prolapse, cohort study
What does this paper add to the literature?
• Patientsdo not necessarily wait on a surgical waiting
list for longer because they are less fit.
• Lengthof wait for surgery does not lead to significant
change in health status.
• Thepaper supports an argument for a pre- and post-
surgery observational study (such as an interrupted time
series) as an alternative to a randomized trial for rectal
prolapse surgery to reliably assess the effects of surgical
interventions in this area. Residual confounding could
be accounted for during statistical analysis.
Introduction
In randomized controlled trials (RCTs), we aim to pre-
vent bias by using randomization. Accordingly, we hope
to avoid systematic differences in important prognostic
characteristics between study intervention arms, such
that any observed differences in outcomes are more
likely to be due to the interventions. Thus, well-con-
ducted RCTs are considered the gold standard in evi-
dence based medicine. Despite a legitimate case for
RCTs, well-known challenges exist when evaluating sur-
gical interventions [1]. Many interventions become rou-
tinely available in practice despite little or no evidence
base. Surgeons and patients then prefer these interven-
tions and may be unhappy with randomization. Mask-
ing or blinding is often difficult, and sham surgery is
controversial.
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One such condition is the treatment of rectal pro-
lapse. This is a condition associated with a significant
negative impact on quality of life. A range of procedures
is used for this including traditional perineal approaches.
More recent innovations include laparoscopic ventral
mesh rectopexy [2]. Advocates of this treatment claim
increased efficacy and improved quality of life. However,
there remain concerns about harms, and it is not clear
which groups might benefit from this compared to tra-
ditional approaches [3]. Despite the best efforts of the
colorectal community, it has not been possible to con-
duct a definitively powered randomized controlled trial
[4]. In the light of the recent mesh controversy, this
may become even more difficult.
Therefore, it is clear that an alternative methodology
is required to investigate the efficacy of rectal prolapse
interventions. Such a methodology should allow robust
comparison of interventions whilst limiting potential
biases. One such design is an interrupted time series
(ITS) [5,6] where outcome data are collected at multi-
ple time points before (i.e. when listed for surgery) and
after surgical intervention to establish whether the inter-
vention results in significant effects accounting for
potential underlying secular trends.
In the case of rectal prolapse, we know waiting times
for surgery vary substantially throughout the National
Health Service (NHS). This offers a natural experiment
where each individual acts as their own control and
allows comparison of outcomes following surgical inter-
vention with concurrent outcomes of patients who wait
longer and have not received the intervention at the
same time point. Conceptually, this is the observational
equivalent of a stepped wedge design for a randomized
trial [7]. Such a study design requires consideration of
what factors influence the wait for surgery. If the wait-
ing time is due to institutional factors unrelated to the
patient they can be considered ‘naturally’ occurring.
This would make the alternative design valid. However,
if patients wait longer because they are ‘sicker’ (chroni-
cally unhealthy) or would get ‘sicker’ than those waiting
a short time they represent different groups and the
design would be invalid.
Our aim was therefore to investigate systematic
differences between those waiting a short time or a long
time for operations of similar intensity and urgency
with respect to patient fitness and health-related quality
of life. A secondary aim was to investigate any detri-
mental effect of surgery waiting duration on change in
health status (from listing for surgery to operation) for
clinically non-urgent surgical procedures. Such data
would provide an indication of whether an ITS type




We conducted a prospective cohort study between Jan-
uary 2017 and February 2019 across seven UK NHS
hospitals. The paper is reported in line with the
STROBE statement [8]. Written informed consent was
obtained and ethical approval was granted by the Chel-
sea Research Ethics Committee (ref: 16/LO/1363).
Inclusion criteria
With rectal prolapse the condition of interest, our target
population was adult patients (≥ 18 years) listed for sur-
gery of the same clinical urgency and intensity as rectal
prolapse surgery, i.e. procedures graded as ‘major’ on
the British United Providential Association (BUPA)
procedure code (Table 1).
Data collection
Following consent, age, sex and comorbidities included
in the Charlson comorbidity index (CCI) [9] were
recorded by one of the research team (research nurse/as-
sistant, clinicians) along with the date of addition to the
surgical waiting list (baseline date). Participants also com-
pleted the EQ-5D-5L questionnaire [10] at baseline. On
admission for surgery, date of admission was recorded
and a second EQ-5D-5L questionnaire was completed.
Outcome measures
The primary outcome was time on the waiting list in
weeks. Explanatory variables included baseline health
Table 1 Eligible surgical procedures.
Eligible procedures according to BUPA
codes
• Any rectal prolapse surgery
• Revision of ileostomy (local and laparotomy)
• Open and laparoscopic operations on small bowel
only
• Closure of ileostomy or colostomy
• Formation of colostomy (open or laparoscopic)
• Elective appendicectomy (open and laparoscopic)
• Repair of anal sphincter
• Laying open of complex or high fistula-in-ano
• Bilateral or recurrent inguinal hernia repair
• Repair of incisional hernia (open and laparoscopic)
• Elective adhesiolysis (open and laparoscopic)
BUPA, British United Provident Association.
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status and comorbidity assessed using EQ-5D-5L and
CCI, respectively. The secondary outcome was the
change in health status whilst awaiting surgery using
EQ-5D-5L.
Definitions of long and short waiters
Current NHS targets require 90% of patients to be oper-
ated within 18 weeks [11,12]. Accordingly patients were
defined as long waiters if the time to surgery exceeded
18 weeks and short waiters, those who waited
≤ 18 weeks. This arbitrary classification of short and long
waiters when exploring the relationship between waiting
time and variables of interest can lead to misleading con-
clusions. To address this concern, further analysis was
performed where the classification was model-based (to
create latent classes) and the relationships between wait-
ing time and variables of interest were assessed within
and across waiting latent classes (see Appendix S1).
Sample size
There were no preliminary data to inform the sample
size calculation. However, with a feasible maximum
sample size of 212 participants, the study had > 90%
power to test the a priori null hypothesis of no associa-
tion versus an alternative hypothesis of an association
for a correlation coefficient of at least 0.2 (between an
outcome and explanatory variable if it exists).
Statistical analysis
Computation of summary scores for analysis
The CCI was derived from the sum of the clinical con-
dition score from 19 comorbidities and age (total score
range 0–37) [9]. Higher scores indicate greater morbid-
ity. We computed the Charlson 10-year survival proba-
bility C10 using the formula
C10 ¼0:983
expð0:9xCCIÞ
EQ-5D-5L was used to measure health status, and a
utility index was derived as previously described [13].
An additional question asks for general health status on
a scale of 0–100, higher values indicating better health.
Waiting time (in weeks) was calculated from the date of
admission for surgery and baseline date.
Preliminary analysis
Patient characteristics and demographics were descrip-
tively summarized (overall and stratified by waiting time
group) depending on the type of variable and underlying
distributions. Violin plots were used to display the distri-
bution of baseline variables stratified by waiting time
group. The Mann–Whitney U test was used to assess dif-
ferences in medians of continuous baseline variables
between the two groups. A non-parametric analysis of
variance (Kruskal–Wallis) test was used to explore
whether waiting times across hospital sites and type of
operations were drawn from the same distribution. Scat-
ter plots were used to explore any relationships between
continuous baseline variables and waiting times.
Finite mixture models
Finite mixture models (FMMs) were developed to
model the probability of patients belonging to each
latent waiting class to estimate linear regression parame-
ters in each class in order, drawing inference within and
between classes. Model performance was assessed using
the Akaike information criterion (AIC). The bimodal
distribution of waiting times strongly suggested that
patients were most likely to belong to two latent wait-
ing classes (see Fig. 1), and this was supported by com-
parison of AIC between models with two and three
latent classes. Cluster-robust standard error FMMs were
selected due to observed variation in waiting time across
centres. To build a multivariable FMM using a linear
regression model, variables were incrementally included
based on the magnitude of the AIC in the univariable
case. Each change in AIC was noted and potential pre-
dictors were selected that yielded the lowest AIC. Using
this model, we estimated the proportion of patients
belonging to a particular class (marginal class probabili-
ties) and mean waiting time in each class with 95% con-
fidence intervals. Contrasts were used to assess
relationships between waiting times and potential pre-
dictors across latent classes. We used FMMs to address
the shortcomings of the preliminary analysis as detailed
in Appendix S2 and reflected in the discussion.
IIn addition to scatter plots, multivariable linear
regression models adjusted for baseline responses
accounting for study site adjusted robust standard errors
were used to assess if changes in the EQ-5D-5L utility
index and general health score were associated with wait-
ing times. Analyses were performed in STATA version 15.1
(College Station, TX, USA).
Results
Patient flow
Of the 219 patients who consented, 16 were excluded
(< 18 years old, n = 2; missing critical data, n = 14).
Comorbidity data were available for 203 patients. Base-
line EQ-5D-5L data were available for 201 patients, of
whom 189 had EQ-5D-5L recorded on the day of sur-
gery (Fig. 2).
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Participant characteristics
The average age (standard deviation) was 53.5 (16.7)
years (range 19.0–89.0), and 129 (64.5%) were women
(Table 2). There were five common types of surgical
operations: rectal prolapse surgery, 39 (19.2%); opera-
tions on the small bowel only, 39 (19.2%); complex fis-
tula-in-ano, 31 (15.3%); closure of stoma, 27 (13.3%);
and repair of incisional hernia, 27 (13.3%). Most patients
(67.5%) had no comorbidity and a CCI median score (in-
terquartile range, IQR) of 1 (0–3) (range 0–12), suggest-
ing a healthy study population (see Table 2).
Variation in wait times across study sites
There was variation in wait times across the population;
range 0.4–68.9 weeks (Fig. 3). Figure 1 shows that the
majority of patients were operated at or before
18 weeks, with a bulge of patients recorded just before
the 18-week time point. Patients in site B waited much
longer for surgery; median waiting time (IQR) 49.7
(45.7–50.7) weeks. The distribution of waiting times in
other sites appeared comparable except for site G, con-
tributing only one patient. The lowest median wait (in
hospitals with > 10 patients) was 11.3 weeks; the high-
est was 49.7 weeks (Fig. 2).
Patient factors associated with wait times
Comorbidity (using the CCI) appeared similar between
the two groups (Fig. 4) [median score (IQR) 2 (0, 3) and
1 (0, 3), respectively]. The type of operation was strongly
associated with waiting times (Kruskal–Wallis test;
P = 0.0093) primarily driven by ‘operations on small
bowel only’ [median (IQR) 45.1 (11.3–49.7) weeks].
There was also strong evidence to support differences in
waiting times across study sites as described above
(Kruskal–Wallis test; P = 0.0001). However, we noted an
interaction between type of surgery and study sites as the
majority of cases of ‘small bowel only’ operations were per-
formed at site B which had the longest waiting times.
For predicting waiting times, the best model
included the type of operation, age, sex, number of
comorbidities and baseline health status as predictors.
Using this model, 79.4% (95% CI 78.1%–80%) and
20.6% (95% CI 19.4%–21.9%) were classified into short
and long waiter latent classes, respectively. These groups
had a mean waiting time of 11.5 and 45.7 weeks,
respectively.
After controlling for other factors (Table 3), there was
a negligible association between age and waiting time,
which was similar among short and long waiters. The
waiting times were similar among male and female short
waiters. However, men waited slightly longer (average of
3.8 more weeks) than women among long waiters. Wait-
ing times were generally comparable across the type of
procedures among short waiters. The association was
uncertain among long waiters due to a small number of
patients undergoing certain surgical procedures. There
was no association between the number of comorbidities
and waiting times among short and long waiters.
Baseline health and wait time
On average, long waiters rated their health status



























Short waiters Long waiters Total
0
Figure 1 Distribution of waiting time by group and overall. Short and long waiters waiting ≤ 18 weeks and > 18 weeks for sur-
gery, respectively.
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on general health total score, short waiters also rated
their general health slightly higher than long waiters
(see Fig. S2). There was insufficient evidence to suggest
marked differences between short and long waiters
(Mann–Whitney U test, P value = 0.41 and P value =
0.40, respectively). The distributions of general health
total scores and health status (utility indices) appear
comparable between short and long waiters.
All patients
(N = 219)
Missing operation waiting time
(n = 14):
Missing baseline date only (n = 1),
Missing surgery date only (n = 11),
Missing baseline and surgery dates
(n = 2)
Patients with waiting time
data available
(n = 203)
Patients with available baseline EQ-
5D-5L data
(n = 201)
Patients with available CCI* data
(n = 203)
Patients with available EQ-5D-5L data
at the time of surgery
(n = 189)
Excluded (n = 2):
Aged<18 years (n = 2)
Missing baseline EQ-5D-5L
information (n = 2)
Missing EQ-5D-5L information
at time of surgery (n =12)
Figure 2 Study flowchart.
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After controlling for age, sex, type of operation
and number of comorbidities, a 0.1 increase in health
utility index was associated with a very small increase
in waiting time of 0.323 and 0.087 weeks among
short and long waiters, respectively (Table 3). There-
fore, the association between baseline health status
and waiting time was negligible and not clinically
worthwhile.
Does health status deteriorate on a waiting list?
Figure 5 shows the relationship between changes in
health utility index and waiting time with a superim-
posed fitted linear regression model adjusted for base-
line health state. There appeared to be a slight trend
suggesting that some patients may improve very mini-
mally in their health status while waiting for surgery.
On average, a 1-week increase in waiting time was asso-
ciated with a negligible improvement in health utility
index of 0.001 (95% CI −0.000 to 0.003). Similar
negligible trends were observed using the general health
rating (see Fig. S3) meaning that we did not detect a
significant change in health status associated with long
wait time. That is, an increase in waiting time by a week
was associated with an improvement in general health
rating of only 0.20 points (95% CI 0.08–0.32). It
should be noted that general health was rated on a scale
of 0–100.
Discussion
This study shows that UK (NHS) patients undergoing
surgical procedures of equivalent intensity and clinical
urgency have highly varied wait times both within and
across hospitals. Specifically, one outlying study site was
the primary driver for long waiting. The study suggests
that neither patient fitness nor health status explains this
wait. Notably, many patients underwent surgery close
to target breach dates, suggesting a system related
explanation for waiting time.
Table 2 Baseline demographics and characteristics of patients.
Variable Scoring
Wait ≤ 18 weeks
(N = 141)




Age Mean (SD) 53.5 (17.7) 53.5 (14.4) 53.5 (16.7)
Median (IQR) 54.0 (38.0, 68.0) 53.5 (42.0, 65.0) 54.0 (39.0, 67.0)
Minimum, maximum 19.0, 89.0 24.0, 84.0 19.0, 89.0
Gender, n (%) (n = 140) (n = 60) (N = 200)
Male 49 (35.0%) 22 (36.7%) 71 (35.5%)
Female 91 (65.0%) 38 (63.3%) 129 (64.5%)
Surgery, n (%) Any rectal prolapse surgery 32 (22.7%) 7 (11.3%) 39 (19.2%)
Bilateral/recurrent inguinal hernia 4 (2.8%) 3 (4.8%) 7 (3.4%)
Closure of ileostomy/colostomy 20 (14.2%) 7 (11.3%) 27 (13.3%)
Elective adhesiolysis (open/laparoscopic) 1 (0.7%) 1 (1.6%) 2 (1.0%)
Elective appendicectomy (open/laparoscopic) 9 (6.4%) 2 (3.2%) 11 (5.4%)
Formation of colostomy (open/laparoscopic) 6 (4.3%) – 6 (3.0%)
Laying open of complex/high fistula-in-ano 27 (19.1%) 4 (6.5%) 31 (15.3%)
Open/laparoscopic operations on small bowel only 17 (12.1%) 22 (35.5%) 39 (19.2%)
Repair of anal sphincter 1 (0.7%) 2 (3.2%) 3 (1.5%)
Repair of incisional hernia (open/laparoscopic) 16 (11.3%) 11 (17.7%) 27 (13.3%)
Revision of ileostomy (local and laparoscopic) 8 (5.7%) 3 (4.8%) 11 (5.4%)
CCI score Median (IQR) 2.0 (0.0, 3.0) 1.0 (0.0, 3.0) 1.0 (0.0, 3.0)
Minimum, maximum 0.0, 12.0 (0.0, 7.0 0.0, 12.0
Number of
comorbidities
None 93 (66.0%) 44 (71.0%) 137 (67.5%)
One 33 (23.4%) 14 (22.6%) 47 (23.2%)
Two 11 (7.8%) 3 (4.8%) 14 (6.9%)
Three or more 4 (2.8%) 1 (1.6%) 5 (2.5%)
EQ-5D-5L index (n = 139) (n = 62) (N = 201)
Median (IQR) 0.79 (0.62, 0.94) 0.83 (0.57, 0.94) 0.80 (0.62, 0.94)




(n = 139) (n = 61) (N = 200)
Median (IQR) 70.0 (50.0, 80.0) 65.0 (45.0, 80.0) 70.0 (50.0, 80.0)
Minimum, maximum 5.0, 100.0 0.0, 100.0 0.0, 100.0
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These findings mean that the patient characteristics
of those who wait longer are comparable to short wait-
ers and that health status does not significantly deterio-
rate or improve while on a waiting list. This could be a
legitimate basis for the use of a pre- and post-surgery
observational study (e.g. an ITS) as an alternative to a
practically and ethically challenging RCT. Such a realis-




























Figure 4 Distribution of baseline Charlson comorbidity index (CCI) score by group and overall. Short and long waiters waiting


































(113) (37) (23) (18) (7)
Site
(4) (1) (203)
A B C D E F G (total)
0
Figure 3 Waiting times by site and overall.
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inference of the benefits of surgical interventions by
comparing patient outcomes assessed repeatedly before
and after the introduction of a surgical procedure of
similar intensity from the point of enlisting for surgery.
This is because the health state does not seem to
change significantly while on the waiting list and wait-
ing time is unlikely to be systematically influenced by
potential confounding factors.
Length of wait from listing to surgery is influenced
by various factors. We controlled for one by limiting
participants to those who have been investigated com-
pletely and appropriately listed for non-urgent non-can-
cer operations of similar intensity. Current UK
standards aim for 90% of these procedures to be com-
pleted within 18 weeks of referral. It is interesting to
note that in our results the violin plots of sites show a
‘bulge’ around the 18-week time point, suggesting that
all centres involved have strived to meet this target in
many cases. The type of operation may also influence
the waiting time. Some operations are more complex
and require special skills, equipment and longer operat-
ing time. In addition, organizational pressures include
preoperative assessment availability, theatre and staff
availability as well as inpatient bed numbers, which vary
across hospitals. Finally, the comorbidity of the patient
may influence wait. For example, a patient with multiple
comorbidities may take longer to achieve a level of fit-
ness that allows routine surgery to occur safely. Or, they
may be deferred due to availability of high dependency
beds, or even indirectly deferred by the clinical team
becoming long waiters.
One would intuitively expect to see an inverse rela-
tionship between health status and the length of wait
for surgery but this was not the case in our cohort. In
fact, we found a very small improvement in health sta-
tus while on a waiting list, especially among long wait-
ers. However, one should be cautious about
interpretation due to small sample size. An explanation
for this might be that the patient was finally admitted
for surgery after a prolonged wait, and this may have
caused a more positive assessment of their own health
state. Either way, this finding should not influence clini-
cal policies.
Other studies have explored the association of wait-
ing time with health-related quality of life [14–17]. Of
perhaps most relevance are data from patients waiting
Table 3 Predictors of waiting time from a multivariable model.
Model predictors
Short waiter class Long waiter class Difference (short/long waiters)
Effect 95% CI P value Effect 95% CI P value Effect 95% CI P value
Age Age 0.032 (−0.012, 0.076) 0.150 0.0311 (0.009, 0.053) 0.005 0.001 (−0.035, 0.036) 0.963
Sex Female (Ref) – – – – – – – –
Male 0.616 (−0.391, 1.623) 0.230 3.758 (3.651, 3.864) <0.001 −3.141 (−4.158, −2.125) <0.001
Surgery Rectal prolapse (Ref) – – – – – – – –
Bilateral/recurrent
inguinal herniaa
−0.403 (−2.524, 1.718) 0.710 −7.869 (−10.156, −5.593) <0.001 7.466 (3.812, 11.120) <0.001
Closure ileostomy/
colostomy
−2.600 (−5.144, −0.056) 0.045 −5.994 (−8.475, −3.512) <0.001 3.394 (−0.636, 7.423) 0.099
Elective adhesiolysisa 8.040 (3.668, 12.412) <0.001 −45.653 (−46.438, −44.868) <0.001 53.693 (49.225, 58.162) <0.001
Elective
appendicectomy
−1.910 (−4.026, 0.205) 0.077 0.765 (−2.080, 3.610) 0.598 −2.676 (−6.786, 1.434) 0.202
Formation of colostomya −3.493 (−9.958, 2.971) 0.289 −34.886 (−35.940, −33.833) <0.001 31.393 (24.183, 38.603) <0.001
Laying open of
complex fistula
−3.119 (−4.491, −1.748) <0.001 −9.382 (−11.263, −7.501) <0.001 6.263 (4.344, 8.181) <0.001
Small bowel only −2.682 (−4.031, −1.333) <0.001 −2.384 (−4.487, −0.282) 0.026 −0.298 (−3.582, 2.986) 0.859
Repair of anal
sphinctera
2.944 (0.545, 5.342) 0.016 −21.185 (−24.209, −18.161) <0.001 24.129 (20.223, 28.035) <0.001
Repair of incisional
hernia
0.283 (−2.010, 2.577) 0.809 2.396 (0.154, 4.637) 0.036 −2.112 (−4.571, 0.346) 0.092
Revision of ileostomy −4.778 (−5.665, −3.890) <0.001 −28.631 (−30.966, −26.295) <0.001 23.853 (20.834, 26.872) <0.001
No. of
comorbidities
0 (Ref) – – – – – – – –
1 −0.775 (−2.438, 0.887) 0.361 0.250 (0.088, 0.411) 0.002 −1.025 (−2.749, 0.699) 0.244




3.234 (1.581, 4.886) <0.001 0.870 (0.095, 1.646) 0.028 2.363 (0.451, 4.275) 0.015
aResults should be interpreted with caution due to very small numbers of patients. Ref is the reference category. P values should be
interpreted with caution in relation to the observed effects. For example, some P values are highly significant for very small or negli-
gible effects because the sample size was large to find those small effects if they exist.
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for elective hernia repair. In this study, the duration of
time on the waiting list was not associated with a
change in self-reported health [18], and patients with
the poorest health tended to improve whilst waiting.
Possible explanations include patients with greater
depression, pain and hernia related symptoms seeking
non-surgical interventions. Alternatively, perceptions of
health were biased by the reassurance of pending sur-
gery. This may explain the static or slightly positive
health status trend seen in long waiters in our study.
The definition of long and short waiters was in line
with current political targets in the UK. This could be
considered as too arbitrary. As those waiting more than
18 weeks tended to be a small proportion of the overall
cohort, any future study may have to be large in order
to capture an adequate number of long waiters. How-
ever, modelling suggests that, even in those who wait
< 18 weeks, there was no significant change in health
status. Therefore, a pre- and post-surgery observational
study could be carried out with smaller numbers of
patients and even those waiting a shorter time for sur-
gery, provided outcomes were measured frequently.
One strength of the study is the use of FMMs to
obviate the problem of arbitrary classification of waiting
time and to handle the bimodal distribution, addressing
the first aim. This allowed exploration of relationships
within and between latent waiting classes. Other
strengths include the prospective, multi-centre design
including multiple surgical procedures of similar inten-
sity and the use of validated outcome measures. How-
ever, there are some weaknesses. First, there were no
data to inform the sample size robustly, although the
feasible sample size was adequate to explore at least
small associations. Second, the sample sizes within each
study site and surgical procedure were relatively small
with limited patients in four surgical procedures and
three sites. This limits inference and subgroup explo-
ration. Third, the population was mainly healthy and it
may not be feasible to extrapolate results to less fit pop-
ulations. However, results do reflect typical rectal pro-
lapse patients. Finally, as outlined earlier in the
discussion, there may be factors not measured here
which have affected waiting times. For example, bed
availability, last minute or on the day cancellations of
surgery, and risk assessment or attitudes to risk of the
clinical team.
The study has implications for researchers in the
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Figure 5 Change in EQ-5D-5L index according to wait time interval.
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surgery observational study (such as an ITS) as a viable
alternative design that could produce reliable causal
inference to assess surgical interventions in this area
where an RCT is not feasible.
Conclusion
This study shows that time on a waiting list is not
strongly associated with functional status or quality of
life. While we would always advocate an RCT where
feasible, it strengthens the argument for using other
designs when conditions are unfavourable, e.g. when
equipoise is poor, which is the case in elective surgery
of intermediate severity such as prolapse surgery.
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